The global parenteral nutrition market size reached US$ 7.2 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 12.2 Billion by 2032, exhibiting a growth rate (CAGR) of 6.03% during 2023-2032.
Parenteral nutrition (PN), or intravenous feeding, offers liquid nutrients like fats, proteins, vitamins, minerals, carbohydrates, and electrolytes. It is a part of specialized nutritional therapy that providing nutritional support to patients who are unable to utilize their gastrointestinal tract. It aids in preventing malnutrition and maintaining energy, hydration, and strength levels. As a result, it is widely used among patients who are suffering from cancer, Crohn’s disease, short bowel syndrome, ischemic bowel disease, and abnormal bowel function.
This, in confluence with the rising incidences of hepatic insufficiency, renal insufficiency and protein-energy malnutrition, is increasing the consumption of amnio acid-rich and parenteral products. The market is further driven by significant improvements in the PN, such as lipid emulsions optimizations and utilization of indirect calorimetry. Some of the other factors, such as increasing expenditure on the overall development of the healthcare sector by the governing agencies and private entities of several countries and rising adoption of PN products by the healthcare sector, are anticipated to strengthen the market growth across the globe.
2. What is the expected growth rate of the global parenteral nutrition market during 2024-2032?
3. What are the key factors driving the global parenteral nutrition market?
4. What has been the impact of COVID-19 on the global parenteral nutrition market?
5. What is the breakup of the global parenteral nutrition market based on the nutrient type?
6. What is the breakup of the global parenteral nutrition market based on the end user?
7. What are the key regions in the global parenteral nutrition market?
8. Who are the key players/companies in the global parenteral nutrition market?
Parenteral nutrition (PN), or intravenous feeding, offers liquid nutrients like fats, proteins, vitamins, minerals, carbohydrates, and electrolytes. It is a part of specialized nutritional therapy that providing nutritional support to patients who are unable to utilize their gastrointestinal tract. It aids in preventing malnutrition and maintaining energy, hydration, and strength levels. As a result, it is widely used among patients who are suffering from cancer, Crohn’s disease, short bowel syndrome, ischemic bowel disease, and abnormal bowel function.
Parenteral Nutrition Market Trends:
The rising prevalence of malnutrition, growing natality rate, and increasing premature births are among the primary factors catalyzing the demand for PN around the world. Moreover, there is a considerable rise in the number of individuals experiencing pediatric disorders, such as asthma, leukemia, tuberculosis, bronchitis, chickenpox, and anemia. This, along with the rising geriatric population, which is relatively more prone to chronic diseases, is also influencing the demand for PN products positively. Furthermore, the growing consumption of fast food has resulted in the growing instances of non-communicable diseases like hypertension, diabetes, obesity, and other metabolic disorders.This, in confluence with the rising incidences of hepatic insufficiency, renal insufficiency and protein-energy malnutrition, is increasing the consumption of amnio acid-rich and parenteral products. The market is further driven by significant improvements in the PN, such as lipid emulsions optimizations and utilization of indirect calorimetry. Some of the other factors, such as increasing expenditure on the overall development of the healthcare sector by the governing agencies and private entities of several countries and rising adoption of PN products by the healthcare sector, are anticipated to strengthen the market growth across the globe.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global parenteral nutrition market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on nutrient type and end user.Breakup by Nutrient Type:
- Carbohydrates
- Lipid Emulsion
- Single Dose Amino Acid Solution
- Trace Elements
- Vitamins and Minerals
Breakup by End User:
- Hospitals
- Clinics
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aculife Healthcare Private Limited, B. Braun Melsungen AG, Baxter International Inc., Fresenius SE & Co. KGaA, Grifols S.A., Otsuka Pharmaceutical Factory Inc., Pfizer Inc. and Servona GmbH.Key Questions Answered in This Report
1. How big is the global parenteral nutrition market?2. What is the expected growth rate of the global parenteral nutrition market during 2024-2032?
3. What are the key factors driving the global parenteral nutrition market?
4. What has been the impact of COVID-19 on the global parenteral nutrition market?
5. What is the breakup of the global parenteral nutrition market based on the nutrient type?
6. What is the breakup of the global parenteral nutrition market based on the end user?
7. What are the key regions in the global parenteral nutrition market?
8. Who are the key players/companies in the global parenteral nutrition market?
Table of Contents
1 Preface3 Executive Summary10 Value Chain Analysis12 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Parenteral Nutrition Market
6 Market Breakup by Nutrient Type
7 Market Breakup by End User
8 Market Breakup by Region
9 SWOT Analysis
11 Porters Five Forces Analysis
13 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Aculife Healthcare Private Limited
- B. Braun Melsungen AG
- Baxter International Inc.
- Fresenius SE & Co. KGaA
- Grifols S.A.
- Otsuka Pharmaceutical Factory Inc.
- Pfizer Inc.
- Servona GmbH
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | August 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 7.2 Billion |
| Forecasted Market Value ( USD | $ 12.2 Billion |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 8 |
